Zenotech Laboratories Ltd
BSE:532039
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
56.47
101.67
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Zenotech Laboratories Ltd
Total Current Liabilities
Zenotech Laboratories Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Total Current Liabilities
₹126.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-16%
|
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Total Current Liabilities
₹990.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Transgene Biotek Ltd
BSE:526139
|
Total Current Liabilities
₹109.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Total Current Liabilities
₹1.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Biocon Ltd
NSE:BIOCON
|
Total Current Liabilities
₹153.6B
|
CAGR 3-Years
56%
|
CAGR 5-Years
36%
|
CAGR 10-Years
27%
|
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Total Current Liabilities
₹3.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Zenotech Laboratories Ltd
Glance View
Zenotech Laboratories Ltd. engages in the manufacture and marketing of pharmaceuticals products. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of manufacturing and marketing biotechnology and pharmaceuticals products. The Company’s injectables product portfolio primarily serves niche therapy areas, such as oncology and anesthesiology. The firm has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
See Also
What is Zenotech Laboratories Ltd's Total Current Liabilities?
Total Current Liabilities
126.1m
INR
Based on the financial report for Sep 30, 2024, Zenotech Laboratories Ltd's Total Current Liabilities amounts to 126.1m INR.
What is Zenotech Laboratories Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-16%
Over the last year, the Total Current Liabilities growth was -17%. The average annual Total Current Liabilities growth rates for Zenotech Laboratories Ltd have been -6% over the past three years , -26% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
